QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=33F0FB99AFBD5F7BA3E7200C08589A76;jsessionid=2AF6AD43DA11B38723A38D06BFE5512C;jsessionid=3A760D4E383458E4D742C32678FCFE63;jsessionid=A435D00982AC3B5696750978CE258BA9;jsessionid=D8476AC87726E66730AAF926514A56C7;jsessionid=2AE9CFE32D0179080B11DAF0533B33E9;jsessionid=C9B4637038B105673DBF8D5BC08C65CE (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=33F0FB99AFBD5F7BA3E7200C08589A76;jsessionid=2AF6AD43DA11B38723A38D06BFE5512C;jsessionid=3A760D4E383458E4D742C32678FCFE63;jsessionid=A435D00982AC3B5696750978CE258BA9;jsessionid=D8476AC87726E66730AAF926514A56C7;jsessionid=2AE9CFE32D0179080B11DAF0533B33E9;jsessionid=C9B4637038B105673DBF8D5BC08C65CE